CiteSpace and VOSviewer⁃based analysis of current status and development trends in lung cancer metastasis research in China over past 20 years

LUO Bin; CHU Xiaoge; LI Jiaxuan; YANG Yun; LI Minghua; WU Jianchun; ZHOU Yiyang; YUAN Si; TIAN Jianhui

doi:10.16305/j.1007-1334.2024.z20240610002

您当前的位置：

首页 >

文章列表页 >

CiteSpace and VOSviewer⁃based analysis of current status and development trends in lung cancer metastasis research in China over past 20 years

更新时间：2024-12-23

- CiteSpace and VOSviewer⁃based analysis of current status and development trends in lung cancer metastasis research in China over past 20 years
- Shanghai Journal of Traditional Chinese Medicine Vol. 58, Issue 12, Pages: 8-15(2024)
- 作者机构：
  
  1.上海市中医医院肿瘤临床医学中心（上海 200071）
  2.上海市中医医院肿瘤研究所（上海 200071）
  3.上海市静安区北站医院血液肿瘤科（上海 200070）
  4.云南省怒江州中医医院肿瘤科（云南泸水 673100）
- 作者简介：
- 基金信息：
- DOI：10.16305/j.1007-1334.2024.z20240610002
  CLC：
- Published：10 December 2024，
  
  Received：10 June 2024，
- 稿件说明：
移动端阅览
罗斌,楚小鸽,李佳轩,等.基于CiteSpace和VOSviewer分析的国内近20年肺癌转移研究现状与发展趋势[J].上海中医药杂志,2024,58(12):8-15.

LUO Bin,CHU Xiaoge,LI Jiaxuan,et al.CiteSpace and VOSviewer⁃based analysis of current status and development trends in lung cancer metastasis research in China over past 20 years[J].Shanghai Journal of Traditional Chinese Medicine,2024,58(12):8-15.
罗斌,楚小鸽,李佳轩,等.基于CiteSpace和VOSviewer分析的国内近20年肺癌转移研究现状与发展趋势[J].上海中医药杂志,2024,58(12):8-15. DOI： 10.16305/j.1007-1334.2024.z20240610002.

LUO Bin,CHU Xiaoge,LI Jiaxuan,et al.CiteSpace and VOSviewer⁃based analysis of current status and development trends in lung cancer metastasis research in China over past 20 years[J].Shanghai Journal of Traditional Chinese Medicine,2024,58(12):8-15. DOI： 10.16305/j.1007-1334.2024.z20240610002.

摘要

目的

探讨国内近20年肺癌转移的研究进展及现状，为未来肺癌转移的基础与临床研究提供思路。

方法

通过中国知网、万方数据知识服务平台、维普中文科技期刊数据库进行文献检索，文献发表时间限定为2003年1月1日至2023年6月30日，语言为中文。应用CiteSpace和VOSviewer软件，对机构、作者、期刊、关键词等进行可视化分析，并绘制相关可视化图谱，分析肺癌转移的研究现状、研究热点及趋势。

结果

在前述数据库中共检索到符合要求的中文文献6 647篇，其中发文量高峰时间在2016年和2020年；发文量最多的机构为上海中医药大学附属龙华医院；总体发文量最多作者为周清华教授，近3年发文量最多作者为田建辉教授；发文量最多的期刊为《中国肺癌杂志》；肺癌转移领域核心热点词为肺癌、非小细胞肺癌、脑转移、骨转移，近3年突现强度排名前3的关键词为靶向治疗、肺腺癌、免疫治疗；近期出现的热点关键词为免疫治疗与影像组学。

结论

近20年国内肺癌转移研究中，中医、西医出现齐头并进趋势，尤其是中医药领域的机构和专家较为突出，研究方向主要聚焦肺癌的脑转移、骨转移，未来的研究热点或为免疫治疗与影像组学，但肺癌转移机制方面的研究仍需完善与加强。

Abstract

Objective

To discuss the research progress and current status of lung cancer metastasis in China in recent 20 years， providing insights for future basic and clinical research on lung cancer metastasis.

Methods

Literature was retrieved from CNKI， Wanfang， and VIP Databases. The publication period was from January 1， 2003 to June 30， 2023， and the language was limited to Chinese. CiteSpace and VOSviewer software were used to perform visual analysis on institutions， authors， journals， and keywords， and to draw relevant visual maps to analyze the current status， hotspots， and trends in lung cancer metastasis research.

Results

A total of 6，647 Chinese articles conforming to the criteria were retrieved from the aforementioned databases. The peak publication years were 2016 and 2020. The institution with the highest number of publications was Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. The author with the highest overall number of publications was Professor Zhou Qinghua， while the author with the most publications in the past three years was Professor Tian Jianhui. The journal with the highest number of publications was the

Chinese Journal of Lung Cancer

. Core hotspot keywords in the field of lung cancer metastasis included lung cancer， non-small cell lung cancer， brain metastasis， and bone metastasis. In the past three years， the top three keywords with the highest burst strengths were targeted therapy， lung adenocarcinoma， and immunotherapy. Recently emerging hotspot keywords included immunotherapy and radiomics.

Conclusions

In the past 20 years， there has been a trend of parallel development in the research of lung cancer metastasis in both traditional Chinese medicine and Western medicine in China. Institutions and experts in the field of traditional Chinese medicine have been particularly prominent. The main research directions have focused on brain and bone metastasis of lung cancer. Future research hotspots may include immunotherapy and radiomics， but research on lung cancer metastasis mechanisms needs further improvement and enhancement.

关键词

肺癌肿瘤转移中医药疗法免疫治疗影像组学文献计量学可视化分析

Keywords

lung cancertumor metastasistraditional Chinese medicine therapyimmunotherapyradiomicsbibliometricsvisual analysis

references

BRAY F， LAVERSANNE M， SUNG H， et al. Global cancer statistics 2022： GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］. CA Cancer J Clin， 2024， 74（3）： 229-263.

TENG Y， XIA C F， CAO M M， et al. Lung cancer burden and trends from 2000 to 2018 in China： Comparison between China and the United States［J］. Chin J Cancer Res， 2023， 35（6）： 618-626.

ZHENG R S， ZHANG S W， ZENG H M， et al. Cancer incidence and mortality in China， 2016［J］.J Natl Cancer Cent， 2022， 2（1）： 1-9.

MARIN-ACEVEDO J A， PELLINI B， KIMBROUGH E O， et al. Treatment strategies for non-small cell lung cancer with common EGFR Mutations： A review of the history of EGFR TKIs approval and emerging data［J］. Cancers （Basel）， 2023， 15（3）： 629.

TEAM C E. Five decades of advances in cancer research［J］. Cell， 2024， 187（7）： 1567-1568.

HANAHAN D. Hallmarks of cancer： new dimensions［J］. Cancer Discov， 2022， 12（1）： 31-46.

MELLMAN I， CHEN D S， POWLES T， et al. The cancer-immunity cycle： Indication， genotype，and immunotype［J］. Immunity， 2023， 56（10）： 2188-2205.

韩懿存，季青. 聚焦肿瘤微环境重塑：中药及其有效成分干预肿瘤复发转移的优势与思考［J］.上海中医药杂志， 2023， 57（4）： 1-7.

周鑫，赵卫红，赵晓，等. 阿可拉定联合常规方案治疗晚期非小细胞肺癌的疗效和安全性价［J］. 解放军医学院学报， 2019， 40（3）： 219-222.

吴世龙，李妍妍. 紫杉醇药物资源的研究概况［J］. 国土与自然资源研究， 2024（4）： 79-83.

须怡晖，王美伊，王歆荷，等. 中医问诊研究热点主题与趋势——基于CiteSpace的文献计量分析［J］. 上海中医药杂志， 2024， 58（3）： 42-46.

岳铭坤，李凯，吴焕淦，等. 国内外针灸领域卫生经济学研究的现状与趋势——基于 CiteSpace和VOSviewer软件分析［J］. 上海中医药杂志， 2024， 58（1）： 8-15.

田建辉，罗斌，阙祖俊，等. 癌症转移亚临床阶段核心病机“正虚伏毒”学说［J］. 上海中医药杂志， 2021， 55（10）： 1-3，13.

程海波，李柳，周学平，等. 中医肿瘤癌毒病机辨证体系的创建［J］. 中医杂志，2020，61（20）： 1767-1770.

MAJEED U， MANOCHAKIAN R， ZHAO Y J， et al. Targeted therapy in advanced non-small cell lung cancer： current advances and future trends［J］. J Hematol Oncol， 2021， 14（1）： 108.

FLOREZ N， KIEL L， RIANO I， et al. Lung cancer in women： The past， present， and future［J］.Clin Lung Cancer， 2024， 25（1）： 1-8.

陈薪如，周彩存. 肺癌内科治疗临床研究十年回顾和现状［J］. 实用肿瘤杂志， 2024， 39（3）： 209-218.

罗斌，阙祖俊，田建辉. 从转移前微环境探讨“邪之所凑，其气必虚”理论对癌症转移防治意义［J］. 广州中医药大学学报， 2023， 40（12）： 3174-3179.

王根旺，吕镗烽. 基于SEER数据库中第一原发肺癌患者的远处转移特征及预后分析［J］.东南国防医药， 2022， 24（4）： 350-355.

田建辉. 扶正治癌调控肿瘤免疫研究［J］. 肿瘤防治研究， 2021， 48（6）： 565-569.

林宏远，张晓维，王文惠，等. 中西医临床实践优势互补融合——清晰定位、肯定疗效和明确机制［J］. 中国中西医结合杂志， 2024， 44（3）： 365-368.

Views

下载量

CSCD

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Research progress on regulation of NK cells by traditional Chinese medicine in prevention and treatment of lung cancer metastasis

Li Yan's experience in treating lung cancer with strengthening vital qi to eliminate pathogenic factor method

Effect of Fuzheng Quxie Formula on progression⁃free survival in lung cancer patients

Effect of Fuzheng Quxie Formula on immune function and disease⁃free survival in postoperative patients with stage ⅠA micropapillary/solid‑dominant positive invasive lung adenocarcinoma

Clinical efficacy of Yiqi Yangyin Jiedu Formula combined with tislelizumab in treatment of driver‑gene‑negative advanced NSCLC and its impact on peripheral immune indicators

Related Author

WANG Yanhong

TIAN Jianhui

LUO Bin

YANG Yun

QUE Zujun

ZHAO Zhenyu

WU Jianchun

ZHANG Bo

Related Institution

Clinical Oncology Center， Shanghai Municipal Hospital of Traditional Chinese Medicine Affiliated to Shanghai University of Traditional Chinese Medicine

Institute of Oncology， Shanghai Municipal Hospital of Traditional Chinese Medicine Affiliated to Shanghai University of Traditional Chinese Medicine

Department of Oncology， Shanghai Hospital of Traditional Chinese Medicine

Shanghai Municipal Hospital of Traditional Chinese Medicine Affiliated to Shanghai University of Traditional Chinese Medicine

Department of Oncology， Shanghai Municipal Hospital of Traditional Chinese Medicine Affiliated to Shanghai University of Traditional Chinese Medicine

⁰